Kurt D’Andrea

13.9k total citations
23 papers, 872 citations indexed

About

Kurt D’Andrea is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Kurt D’Andrea has authored 23 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Kurt D’Andrea's work include BRCA gene mutations in cancer (6 papers), Melanoma and MAPK Pathways (5 papers) and Cancer Genomics and Diagnostics (5 papers). Kurt D’Andrea is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Melanoma and MAPK Pathways (5 papers) and Cancer Genomics and Diagnostics (5 papers). Kurt D’Andrea collaborates with scholars based in United States, Australia and United Kingdom. Kurt D’Andrea's co-authors include Katherine L. Nathanson, Bradley Wubbenhorst, Richard Letrero, Nandita Mitra, Adam Kraya, David J. Margolis, Ole Hoffstad, Sanika Khare, Daniel DeSloover and Richard Kefford and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kurt D’Andrea

22 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kurt D’Andrea United States	14	452	238	235	197	185	23	872
Bradley Wubbenhorst United States	14	449 1.0×	281 1.2×	311 1.3×	198 1.0×	124 0.7×	28	1.0k
Thorunn Helgason United States	15	467 1.0×	427 1.8×	342 1.5×	131 0.7×	53 0.3×	31	1.1k
Kathy A. Toy United States	17	666 1.5×	358 1.5×	340 1.4×	91 0.5×	47 0.3×	19	999
Mert Sozen Türkiye	9	687 1.5×	512 2.2×	170 0.7×	62 0.3×	114 0.6×	20	1.3k
Ulrike Lacher Germany	10	631 1.4×	295 1.2×	284 1.2×	59 0.3×	131 0.7×	14	942
Dawn Steele United Kingdom	8	398 0.9×	410 1.7×	256 1.1×	95 0.5×	44 0.2×	8	761
F Kasumi Japan	16	686 1.5×	529 2.2×	530 2.3×	373 1.9×	127 0.7×	53	1.4k
Elina Eriksson Sweden	13	287 0.6×	259 1.1×	286 1.2×	72 0.4×	44 0.2×	15	653
Frank Mross Switzerland	3	521 1.2×	515 2.2×	362 1.5×	105 0.5×	66 0.4×	7	1.0k
Yvonne T.M. Tsang United States	18	533 1.2×	329 1.4×	211 0.9×	67 0.3×	93 0.5×	24	1.2k

Countries citing papers authored by Kurt D’Andrea

Since Specialization

Citations

This map shows the geographic impact of Kurt D’Andrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt D’Andrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt D’Andrea more than expected).

Fields of papers citing papers by Kurt D’Andrea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt D’Andrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt D’Andrea. The network helps show where Kurt D’Andrea may publish in the future.

Co-authorship network of co-authors of Kurt D’Andrea

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt D’Andrea. A scholar is included among the top collaborators of Kurt D’Andrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt D’Andrea. Kurt D’Andrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pyle, Louise C., Jung Kim, Jonathan P. Bradfield, et al.. (2023). Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes. European Urology. 85(4). 337–345. 5 indexed citations

Maxwell, Kara N., Vishal Patel, Kevin T. Nead, et al.. (2022). Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood. Clinical Genetics. 103(1). 119–124. 3 indexed citations

Shah, Jennifer, Dana Pueschl, Bradley Wubbenhorst, et al.. (2022). Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nature Communications. 13(1). 6728–6728. 14 indexed citations

Gray, G. Kenneth, Carman Man-Chung Li, Jennifer M. Rosenbluth, et al.. (2022). A human breast atlas integrating single-cell proteomics and transcriptomics. Developmental Cell. 57(11). 1400–1420.e7. 76 indexed citations

Torres, Alexandra, Kurt D’Andrea, Vivek Narayan, et al.. (2022). Abstract OT2-18-01: Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer. Cancer Research. 82(4_Supplement). OT2–18. 2 indexed citations

Mitra, Nandita, Bradley Wubbenhorst, Kurt D’Andrea, et al.. (2019). Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence. Annals of Allergy Asthma & Immunology. 123(6). 595–601.e1. 12 indexed citations

Margolis, David J., Nandita Mitra, Bradley Wubbenhorst, et al.. (2018). Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans. Journal of Investigative Dermatology. 138(7). 1501–1506. 57 indexed citations

Margolis, David J., N. K. Mitra, Kurt D’Andrea, et al.. (2018). 259 Uncommon filaggrin variants are associated with persistent atopic dermatitis in African-Americans. Journal of Investigative Dermatology. 138(5). S44–S44. 2 indexed citations

Wilson, Melissa, Fengmin Zhao, Sanika Khare, et al.. (2015). Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma. Clinical Cancer Research. 22(2). 374–382. 31 indexed citations

10.

Fishbein, Lauren, Sanika Khare, Bradley Wubbenhorst, et al.. (2015). Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nature Communications. 6(1). 6140–6140. 138 indexed citations

11.

Maxwell, Kara N., Bradley Wubbenhorst, Brandon M. Wenz, et al.. (2015). Abstract 2990: Evidence for diverse mechanisms of tumorigenesis in breast and ovarian tumors of BRCA1/2 carriers. Cancer Research. 75(15_Supplement). 2990–2990. 2 indexed citations

12.

Maxwell, Kara N., Brandon M. Wenz, Bradley Wubbenhorst, et al.. (2015). Characteristics of high risk breast cancer patients with mutations identified by multiplex panel testing.. Journal of Clinical Oncology. 33(15_suppl). 1511–1511.

13.

Wilson, Melissa, Fengmin Zhao, Richard Letrero, et al.. (2014). Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and Sorafenib. Clinical Cancer Research. 20(12). 3328–3337. 30 indexed citations

14.

Maxwell, Kara N., Bradley Wubbenhorst, Kurt D’Andrea, et al.. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genetics in Medicine. 17(8). 630–638. 106 indexed citations

15.

Koster, Roelof, Nandita Mitra, Kurt D’Andrea, et al.. (2014). Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors. Human Molecular Genetics. 23(22). 6061–6068. 25 indexed citations

16.

Maxwell, Kara N., Bradley Wubbenhorst, Bradley Garman, et al.. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in patients with early onset breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 1510–1510. 1 indexed citations

17.

Nathanson, Katherine L., Anne‐Marie Martin, Bradley Wubbenhorst, et al.. (2013). Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436). Clinical Cancer Research. 19(17). 4868–4878. 132 indexed citations

18.

Jilaveanu, Lucia B., Fengmin Zhao, Christopher R. Zito, et al.. (2013). Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel. PLoS ONE. 8(8). e69748–e69748. 2 indexed citations

19.

Dondeti, Vijay R., Bradley Wubbenhorst, Priti Lal, et al.. (2011). Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma Define Disease Subtypes and Potential New Therapeutic Targets. Cancer Research. 72(1). 112–121. 43 indexed citations

20.

Kanetsky, Peter A., Nandita Mitra, Saran Vardhanabhuti, et al.. (2011). A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Human Molecular Genetics. 20(15). 3109–3117. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact